Protai
Engineering Software · Israel · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Tel Aviv, Tel Aviv, IsraelWebsite
protai.bioRevenue
<$5 MillionIndustry
About Protai
Protai Org Chart
Is Protai your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Protai launches new products
Protai, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Protai
Check if Protai has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Protai has new funding data
Check out if Protai is spiking on competitors!
Earning: See what the market has to say on Protai recently announced quarterly report
Click to see if Protai had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Protai as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Protai is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Protai is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Protai.
Protai financials insights
Gather financial insights about Protai, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Angel/Seed
$8M
Angel/Seed
$12M
Protai Tech Stack
A closer look at the technologies used by Protai
Protai News & Media
Protai to showcase groundbreaking AIMS™ drug discovery platform and best-in-class PRT001 KAT6A degrader results at spring 2026 global conferences.
TEL AVIV, Israel, Feb. 10, 2026 /PRNewswire/ -- Protai, www.protai.bio, an AI drug discovery startup, announced its participation in a series of major scientific conferences this spring, where it will present significant advances in its AIMS™ proteomics-aware-AI drug discovery platform...Protai Showcases Breakthroughs in Structural-Proteomics & AI Driven Drug Discovery at October Global Conferences
RAMAT GAN, Israel, Oct. 23, 2025 /PRNewswire/ -- Protai, www.protai.bio, a structural proteomics and AI-driven biotech, announced its participation in four major scientific conferences this October, presenting pioneering advances in targeted protein degradation, TNFα signaling complex...Protai Strengthens Advisory Board with Top Scientific Talent to Drive Drug Discovery and Support Expansion to Immunology & Inflammation
RAMAT GAN, Israel, Oct. 15, 2025 /PRNewswire/ -- Protai, a structural-proteomics & AI driven biotech, has announced the addition of three leading scientists to its advisory board. This move is set to accelerate the company's drug discovery programs and reinforce its expansion into the...Protai adds $12 million to Seed round as it aims to build oncology drug discovery pip | Ctech
The Israeli startup, which has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level, aims to better predict which patients will respond to a given drug as well as discover novel drug targets that were missed by genomic approaches
Top Engineering Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Protai
Founded in 2021 and headquartered in Tel Aviv, Israel, Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat complex diseases.... Read More